Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sramek

Showing results (71-80 of 156) with videos related to

Pageof 16
Sort By:
British Journal of Clinical Pharmacology|March 1, 1995
Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemiaN Cutler, J Sramek, A Veroff, et al.
The Annals of Pharmacotherapy|September 1, 1996
Placebo response in anxiety disordersM A Piercy, J J Sramek, N M Kurtz, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1992
Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's diseaseN R Cutler, J J Sramek, M F Murphy, et al.
American Journal of Hypertension|December 1, 1993
Compliance in hypertension: daily v twice dailyJ J Sramek, N R Cutler, R D Seifert, et al.
Archives of Biochemistry and Biophysics|June 1, 1977
Substrate-induced conformational changes and half-the-sites reactivity in the Escherichia coli CoA transferaseS J Sramek, F E Frerman, D J McCormick, et al.
The Journal of Clinical Psychiatry|June 1, 1986
Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective studyJ J Sramek, G M Simpson, R L Morrison, et al.
Journal of Psychiatry & Neuroscience : JPN|March 1, 1991
Negative symptoms: psychopathological modelsJ Ananth, A Djenderdjian, P Shamasunder, et al.
Journal of Clinical Psychopharmacology|October 1, 1988
The effect of carbamazepine on hematological hepatic function in chronic schizophreniaJ F Costa, C Heh, T Tram-Johnson, et al.
Hospital & Community Psychiatry|June 1, 1991
Prevalence of tardive dyskinesia among three ethnic groups of chronic psychiatric patientsJ Sramek, S Roy, T Ahrens, et al.
Depression and Anxiety|June 5, 1999
Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxietyJ J Sramek, W W Hong, S Hamid, et al.
Pageof 16

Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
British Journal of Clinical Pharmacology|March 1, 1995
Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemiaN Cutler, J Sramek, A Veroff, et al.
The Annals of Pharmacotherapy|September 1, 1996
Placebo response in anxiety disordersM A Piercy, J J Sramek, N M Kurtz, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1992
Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's diseaseN R Cutler, J J Sramek, M F Murphy, et al.
American Journal of Hypertension|December 1, 1993
Compliance in hypertension: daily v twice dailyJ J Sramek, N R Cutler, R D Seifert, et al.
Archives of Biochemistry and Biophysics|June 1, 1977
Substrate-induced conformational changes and half-the-sites reactivity in the Escherichia coli CoA transferaseS J Sramek, F E Frerman, D J McCormick, et al.
The Journal of Clinical Psychiatry|June 1, 1986
Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective studyJ J Sramek, G M Simpson, R L Morrison, et al.
Journal of Psychiatry & Neuroscience : JPN|March 1, 1991
Negative symptoms: psychopathological modelsJ Ananth, A Djenderdjian, P Shamasunder, et al.
Journal of Clinical Psychopharmacology|October 1, 1988
The effect of carbamazepine on hematological hepatic function in chronic schizophreniaJ F Costa, C Heh, T Tram-Johnson, et al.
Hospital & Community Psychiatry|June 1, 1991
Prevalence of tardive dyskinesia among three ethnic groups of chronic psychiatric patientsJ Sramek, S Roy, T Ahrens, et al.
Depression and Anxiety|June 5, 1999
Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxietyJ J Sramek, W W Hong, S Hamid, et al.
Pageof 16